acetylgalactosamine has been researched along with atorvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Hou, X; Li, B; Li, W; Zeng, C; Zhang, C; Zhang, X; Zhang, Y | 1 |
| Brown, AP; Kallend, D; Lehoux, D; Wijngaard, PLJ; Zerler, B | 1 |
2 other study(ies) available for acetylgalactosamine and atorvastatin
| Article | Year |
|---|---|
Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR).
Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Atorvastatin; Cell Line, Tumor; Hepatocytes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligands; Receptors, LDL; Swine | 2019 |
The N-Acetylgalactosamine-conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low-density lipoprotein cholesterol reductions.
Topics: Acetylgalactosamine; Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macaca fascicularis; Proprotein Convertase 9; RNA, Small Interfering | 2023 |